Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Biosimilars: SOP for Temperature Excursions During Fermentation – V 2.0

Posted on By


Biosimilars: SOP for Temperature Excursions During Fermentation – V 2.0


Standard Operating Procedure for Handling Temperature Excursions During Fermentation in Biosimilar Manufacturing

Department Biosimilars
SOP No. SOP/BS/132/2025
Supersedes SOP/BS/132/2022
Page No. Page 1 of 12
Issue Date 04/05/2025
Effective Date 06/05/2025
Review Date 04/05/2026

1. Purpose

To outline the procedure for detecting, documenting, investigating, and responding to temperature excursions during fermentation processes in biosimilar manufacturing, ensuring product quality and regulatory compliance.

2. Scope

This SOP applies to all fermentation operations involving mammalian, bacterial, or yeast systems in upstream biosimilar production, where temperature is a critical process parameter (CPP).

3. Responsibilities

  • Production: Monitor and immediately report temperature deviations.
  • Engineering: Investigate equipment or utility faults and rectify.
  • QA: Evaluate deviation impact and disposition of the affected batch.

4. Accountability

The Production Head is accountable for ensuring that all temperature excursions during fermentation are promptly addressed, risk-assessed, and documented as per GMP requirements.

5. Procedure

5.1 Monitoring and Detection

  1. Fermenter temperature must be continuously monitored via SCADA or validated data logger.
  2. Alarm should be triggered when temperature deviates by ±0.5°C from the setpoint for ≥5 minutes.
  3. Operator shall acknowledge alarm and record in Annexure-1: Excursion Log Sheet.

5.2 Immediate Action

  1. Identify nature of excursion:
    • High temperature (> upper limit)
    • Low temperature (< lower limit)
  2. Switch to manual temperature control if needed.
  3. Contact engineering for verification of:
    • Jacket heating/cooling loop
    • Temperature sensor calibration
    • Utility supply stability

5.3 Documentation

  1. Log event details including:
    • Start and end time
    • Minimum/Maximum temperatures reached
    • Duration of excursion
  2. Fill Annexure-2: Temperature Excursion Investigation Form.

5.4 Risk Assessment and Batch Impact Evaluation

  1. QA shall lead cross-functional evaluation considering:
    • Stage of fermentation during excursion
    • Duration and deviation magnitude
    • Historical impact on product quality (titer, impurity)
  2. Decision to continue, reprocess, or reject must be documented in Annexure-3.

5.5 Corrective and Preventive Action (CAPA)

  1. CAPA shall be initiated if:
    • Excursion repeats
    • System fault identified
    • Deviation affects product CQAs
  2. Assign responsible person, timeline, and closure details in Annexure-4.

6. Abbreviations

  • CPP: Critical Process Parameter
  • CQA: Critical Quality Attribute
  • SCADA: Supervisory Control and Data Acquisition
  • CAPA: Corrective and Preventive Action

7. Documents

  1. Excursion Log Sheet – Annexure-1
  2. Temperature Excursion Investigation Form – Annexure-2
  3. Batch Disposition Summary – Annexure-3
  4. CAPA Log – Annexure-4

8. References

  • ICH Q8 – Pharmaceutical Development
  • ICH Q9 – Quality Risk Management
  • EU GMP Annex 15 – Qualification and Validation

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Excursion Log Sheet

Date Batch No. Setpoint Deviation Time In/Out Action Taken
04/05/2025 BS-FER-108 37°C 38.3°C 03:10–03:25 Manual reset

Annexure-2: Temperature Excursion Investigation Form

Batch No. Description Suspected Cause Impact Summary Investigated By
BS-FER-108 Temp spike above 1.3°C Steam valve stuck No quality impact Sunita Reddy

Annexure-3: Batch Disposition Summary

Batch No. Review Outcome Disposition QA Signoff
BS-FER-108 Acceptable excursion Released QA

Annexure-4: CAPA Log

CAPA No. Issue Action Owner Status
CAPA-157 Frequent valve malfunction Install new control module Engineering Open

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
04/05/2025 2.0 Annexures added, manual control steps clarified Audit Finding
See also  Biosimilars: SOP for Polishing Step Using Size Exclusion Chromatography - V 2.0
Biosimilars V 2.0 Tags:biosimilar manufacturing SOP, biosimilar process validation SOP, biosimilar quality control procedure, cell line development SOP biosimilars, chromatography SOP biosimilars, cleaning validation SOP for biosimilar equipment, cleanroom SOP for biologics manufacturing, deviation handling SOP in bioprocess, downstream processing SOP, environmental monitoring SOP biosimilars, GMP SOP for biosimilars, host cell protein removal SOP, inline UV monitoring SOP biosimilars, media preparation SOP for biosimilars, protein purification SOP, purification skid calibration SOP, SOP for bioreactor inoculation biosimilars, SOP for biosimilar cell banking, SOP for cell culture in biosimilar production, SOP for chromatography column packing, SOP for ELISA-based clone screening, SOP for endotoxin testing in biologics, SOP for filter sterilization in downstream processing, SOP for glycosylation analysis in biosimilars, SOP for master cell bank, SOP for protein A chromatography steps, SOP for resin qualification in biosimilar purification, SOP for viral clearance in biosimilar production, SOP for working cell bank, upstream processing SOP biosimilars

Post navigation

Previous Post: Analytical Method Development: SOP for SEM Analysis of Particle Morphology – V 2.0
Next Post: Gel Manufacturing: SOP for Handling Stability Failures in Gels – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version